Published in Mol Endocrinol on March 01, 1999
Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol (2006) 2.45
Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest (2003) 1.83
Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol (2004) 1.55
Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Br J Cancer (2006) 1.49
Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal (2009) 1.35
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene (2007) 1.24
IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Lett (2013) 0.98
Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection. Infect Immun (2003) 0.92
PI3K: An Attractive Candidate for the Central Integration of Metabolism and Reproduction. Front Endocrinol (Lausanne) (2012) 0.90
Decreased IGF type 1 receptor signaling in mammary epithelium during pregnancy leads to reduced proliferation, alveolar differentiation, and expression of insulin receptor substrate (IRS)-1 and IRS-2. Endocrinology (2011) 0.86
Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2. Mol Cancer Res (2008) 0.82
Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci (2011) 0.81
Roles of progesterone receptor A and B isoforms during human endometrial decidualization. Mol Endocrinol (2015) 0.80
Estrogen-enhanced gene expression of lipoprotein lipase in heart is antagonized by progesterone. Endocrinology (2007) 0.79
Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancer. Breast Cancer Res Treat (2011) 0.77
An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell (1986) 5.22
The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci U S A (1991) 1.74
Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers. J Pathol (2006) 1.66
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia. Leuk Res (2010) 1.51
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia (2005) 1.47
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia (2006) 1.22
Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells. Leuk Res (2008) 1.19
Introduction of estrogen-responsiveness into mammalian cell lines. Nucleic Acids Res (1986) 1.11
Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol Cell Biol (1990) 1.07
ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia (2003) 1.06
A cell-specific activator in the Xenopus A2 vitellogenin gene: promoter elements functioning with rat liver nuclear extracts. EMBO J (1988) 1.03
Elements and factors involved in tissue-specific and embryonic expression of the liver transcription factor LFB1 in Xenopus laevis. Mol Cell Biol (1993) 1.02
Clinical and mutation data in 12 patients with the clinical diagnosis of Nager syndrome. Hum Genet (2013) 1.00
Developmental regulation and tissue distribution of the liver transcription factor LFB1 (HNF1) in Xenopus laevis. Mol Cell Biol (1993) 0.98
Human insulin receptor substrate-2: gene organization and promoter characterization. Diabetes (1999) 0.96
Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas. Oncogene (1999) 0.96
Identification of a transactivation function in the progesterone receptor that interacts with the TAFII110 subunit of the TFIID complex. J Biol Chem (1995) 0.96
Estrogen and progesterone receptor-binding sites on the chicken vitellogenin II gene: synergism of steroid hormone action. Mol Cell Biol (1988) 0.94
Estrogen-inducible derivatives of hepatocyte nuclear factor-4, hepatocyte nuclear factor-3 and liver factor B1 are differently affected by pure and partial antiestrogens. Eur J Biochem (1994) 0.93
A highly specific and sensitive monoclonal antibody detecting histidine-tagged recombinant proteins. Protein Eng (1995) 0.89
Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia. Acta Haematol (2006) 0.89
Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol (2000) 0.89
The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia. Leukemia (2011) 0.89
E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex. Mol Cell Biol (2000) 0.85
The "additional subunit" CF0II of the photosynthetic ATP-synthase and the thylakoid polypeptide, binding ferredoxin NADP reductase: are they different? Z Naturforsch C (1991) 0.85
Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4. Cell Mol Life Sci (2005) 0.83
A 439 kb-sized homozygous deletion in 17p13.3 leading to biallelic loss of the ASPA as cause of Canavan disease detected by SNP-array analysis. Mol Genet Metab (2009) 0.82
Identification of novel antigens in blood vessels in rectovaginal endometriosis. Mol Hum Reprod (2007) 0.81
TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells. Anticancer Res (2012) 0.80
Liver specific transcription factors of the HNF3-, C/EBP- and LFB1-families interact with the A-activator binding site. Nucleic Acids Res (1991) 0.80
Chimeric liver transcription factors LFB1 (HNF1) containing the acidic activation domain of VP16 act as positive dominant interfering mutants. J Biol Chem (1993) 0.79
Synergistic enhancement of PRB-mediated RU486 and R5020 agonist activities through cyclic adenosine 3',5'-monophosphate represents a delayed primary response. Mol Endocrinol (1998) 0.79
Activation of transcription by progesterone receptor involves derepression of activation functions by a cofactor. Mol Endocrinol (1997) 0.78
Regulation of gene expression in endothelial cells: the role of human follicular fluid. J Mol Endocrinol (2005) 0.78
Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma. Int J Oncol (2013) 0.78
[Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation]. Pathologe (2010) 0.77
Recombinant activation domains of virion protein 16 and human estrogen receptor generate transcriptional interference in vitro by distinct mechanisms. Mol Endocrinol (1993) 0.76
Genomic structure of the Xenopus laevis liver transcription factor LFB1. Gene (1993) 0.75
Cooperative interactions of steroid hormone receptors with their cognate response elements. Cold Spring Harb Symp Quant Biol (1988) 0.75
Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy. Klin Padiatr (2003) 0.75
Aspirin and thrombinogenesis. Thromb Res (2003) 0.75